Sandeep Sapra
About Sandeep Sapra
Sandeep Sapra has 30 years in corporate governance. Holds Partner and Managing Director roles. Currently with 5 companies, including Dnd Build Estate Llp and Amol Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Dnd Build Estate Llp
AAZ-2678
|
Partner | 29 Oct 2021 | 2021 | Active |
Amol Pharmaceuticals Private Limited
U24230RJ1996PTC097657
|
Managing Director | 01 Mar 1996 | 1996 | Active |
|
Amol Properties Private Limited
U45200RJ2003PTC097656
|
Director | 22 Sep 2003 | 2003 | Active |
| Partner | 17 Apr 2024 | 2024 | Active | |
|
Appl Pharmalab Private Limited
U21001RJ2023PTC091901
|
Director | 30 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Ameravite Healthcare Private Limited
U85190MH2008PTC186063
|
Director | 21 Aug 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Sapra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Sapra
Sandeep Sapra has 30 years in corporate governance. Holds Partner and Managing Director roles. Currently with 5 companies, including Dnd Build Estate Llp and Amol Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Sandeep Sapra is associated with 5 companies as Partner and Managing Director.
Sandeep Sapra has expertise in General Business, Healthcare.
Sandeep Sapra has 30 years in corporate governance.